ANANDAN, SHAMUNDEESWARI, MS biotechnology, PhD, is currently pursuing her post-doc project under Prof. Kjell-Morten Myhr, as part of the Clinical Neurology and Biomarker Research Group. Her project aims at establishing unique brain-derived blood based exosomal biomarkers for personalized anti-CD20 therapy, first of its kind, deciphering the immune status between central nervous system and circulating blood in relapsing MS patients. Hence, the overall goal is to optimize treatment outcomes and reduce the frequency of adverse effects.
Email: samanandhan@gmail.com / Shamundeeswari.Anandan@uib.no
UiB Webpage: https://www.uib.no/en/persons/Shamundeeswari.Anandan
